Scarica l'app Stockscreener
1.95
13.33%
-0.30
Dermata Therapeutics Inc Borsa (DRMA) Ultime notizie
Analytical Overview: Dermata Therapeutics Inc (DRMA)’s Ratios Tell a Financial Story - The Dwinnex
A Look at Dermata Therapeutics Inc (DRMA) Shares in the Recent Past Indicates Growth - SETE News
Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - StockTitan
Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - StockTitan
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket - Benzinga
Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary - Benzinga
Ensysce Biosciences (NASDAQ:ENSC) Stock Quotes, Forecast and News Summary - Benzinga
Acne Vulgaris Market Size is Set for Rapid Growth as Innovative - openPR
Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 - StockTitan
Prepare Yourself for Liftoff: Dermata Therapeutics Inc (DRMA) - SETE News
Can you now get a good deal on Dermata Therapeutics Inc’s shares? - US Post News
Daily Market Movement: Dermata Therapeutics Inc (DRMA) Sees a 1.16 Increase, Closing at 1.74 - The Dwinnex
Axillary Hyperhidrosis Market Expected to Experience Major - openPR
Maxim cuts Dermata Therapeutics stock target, retains buy on dilution risk - Investing.com India
Maxim cuts Dermata Therapeutics stock target, retains buy on dilution risk - Investing.com
Maxim Group Lowers Dermata Therapeutics (NASDAQ:DRMA) Price Target to $6.00 - Defense World
Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Lags Revenue Estimates - MSN
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - Yahoo Finance
3 Penny Stocks to Watch Now, 8/6/24 - TipRanks
Take off with Dermata Therapeutics Inc (DRMA): Get ready for trading - SETE News
Dermata Therapeutics expands offering by $505,000 - Investing.com Australia
Dermata Therapeutics expands offering by $505,000 - Investing.com
Dermata Therapeutics expands offering by $505,000 - Investing.com UK
Dermata Therapeutics Inc [DRMA] moved up 44.19: Why It’s Important - The DBT News
Daily Market Movement: Dermata Therapeutics Inc (DRMA) Sees a 44.19 Increase, Closing at 2.48 - The Dwinnex
United States shares lower at close of trade; Dow Jones Industrial Average down 1.21% - Investing.com India
Why did Dermata Therapeutics Inc (NASDAQ: DRMA) surge today ? - BP Journal
DRMA’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.21% - Investing.com
Dermata Therapeutics, Inc. (NASDAQ:DRMA) Short Interest Up 141.3% in July - Defense World
Windtree Therapeutics (WINT) Advancing Cardiac Innovation with Istaroxime - BP Journal
Anitra (AMEX:AZTR) Stock Quotes, Forecast and News Summary - Benzinga
Dermata Therapeutics Inc [DRMA] fell -70.82% so far this year. What now? - The DBT News
Holdings of Dermata Therapeutics Inc (DRMA) are aligned with the stars - SETE News
Actinium Pharmaceuticals (ATNM) Unveils Promising Advances in Targeted Radiotherapies for Cancer Treatment - WICZ
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace
Viking Therapeutics stock (VKTX) could hit all time high and here’s why - BP Journal
Pieris Pharmaceuticals ($PIRS) and Palvella Therapeutics Announce Exciting Merger - BP Journal
Is today’s surge in Dermata Therapeutics (DRMA) justified ? - BP Journal
Dermata Therapeutics Shares Are Trading Over 100%: What You Need To Know - Benzinga
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Benzinga
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings - Benzinga
Why Is Azitra (AZTR) Stock Down 75% Today? - InvestorPlace
Why Is Dermata Therapeutics (DRMA) Stock Up 200% Today? - InvestorPlace
Comparing Roivant Sciences (NASDAQ:ROIV) and Dermata Therapeutics (NASDAQ:DRMA) - Defense World
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace
Market Momentum: Dermata Therapeutics Inc (DRMA) Registers a -23.53 Decrease, Closing at 1.30 - The Dwinnex
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Why Is Nuzee (NUZE) Stock Up 133% Today? - InvestorPlace
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Benzinga
Will MIRA Pharmaceuticals MIRA Stock Keep Surging further on Promising Preclinical Data for Ketamir-2 - BP Journal
Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne - Yahoo Finance
Dermata Therapeutics, Inc. (NASDAQ:DRMA) Sees Large Growth in Short Interest - Defense World
DRMADermata Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Dermata Therapeutics Inc: Rising -90.28% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
Qualigen Therapeutics (QLGN) Secures New Financing to Propel Growth - BP Journal
DouYu (DOYU) Announces Special Dividend causing stock prices to surge - BP Journal
Short Interest in Dermata Therapeutics, Inc. (NASDAQ:DRMA) Drops By 20.0% - Defense World
Halozyme ($HALO): Analyzing the Latest Wall Street Insights and Forecasts - BP Journal
Acne Vulgaris Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by ... - openPR
Dermata (DRMA) Gains on Positive FDA Response for Acne Candidate - Yahoo Sport Australia
Scinai Immunotherapeutics Ltd ($SCNI) Announces Significant Financial Restructuring to Boost Shareholder Equity - BP Journal
Are the recent gains on Longeveron Inc (NASDAQ: LGVN) sustainable ? - BP Journal
SBA Announces $30 Million in Grant Funding for New Women’s Business Centers - Yahoo Finance
Upward Trajectory: Dermata Therapeutics Inc (DRMA) Posts a Gaine, Closing at 3.62 – DWinneX - The Dwinnex
1.16%
2.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):